More Issues for CRISPR Therapeutics: Another CAR-T Failure in Solid Tumors
More Issues for CRISPR Therapeutics: Another CAR-T Failure in Solid Tumors
This week on the podcast Agustin discusses the recent data release from CRISPR Therapeutics, Galapagos' CAR-T cell thera... Read more
5 Jul 2022
•
44mins
How to Navigate Biotech with Maxim Jacobs
How to Navigate Biotech with Maxim Jacobs
This week on the podcast Agustin sits down with Maxim Jacobs. Maxim is a senior vice president at Russo Partners and has... Read more
27 Jun 2022
•
55mins
Similar Podcasts
Major Win for GSK and Uncertainty for Infinity Pharmaceuticals
Major Win for GSK and Uncertainty for Infinity Pharmaceuticals
On this week's episode, Agustin discusses the recent data release of Jemperli and how it may be a viable solution for dM... Read more
21 Jun 2022
•
1hr 5mins
The Failure of TIGIT Antibodies and the battle for KRAS Superiority
The Failure of TIGIT Antibodies and the battle for KRAS Superiority
On this week's episode, Agustin discusses the failures of targeting TIGIT antibodies, the competitive race for KRAS supe... Read more
13 Jun 2022
•
37mins
Sneak Peak into ASCO and Conflicting $PDSB Data
Sneak Peak into ASCO and Conflicting $PDSB Data
On this week's episode, Agustin shares some preliminary insights from ASCO and dives into both the lack of data from $AF... Read more
7 Jun 2022
•
39mins
The Future of TechBio: One on One with Jeff Galvin of American Gene Technologies
The Future of TechBio: One on One with Jeff Galvin of American Gene Technologies
This week on the podcast Agustin sits down with Jeff Galvin, the CEO and founder of American Gene Technologies, an innov... Read more
24 May 2022
•
59mins
One on One Interview with BioMark Diagnostics CEO
One on One Interview with BioMark Diagnostics CEO
This week on the podcast Agustin sits down with Rashid Bux, the CEO and founder of BioMark Diagnostics, an early stage i... Read more
16 May 2022
•
47mins
The Winners and Losers of AACR
The Winners and Losers of AACR
On this week's episode, Agustin highlights the winners and losers of this years AACR conference and discusses how $TGTX ... Read more
25 Apr 2022
•
50mins
Bad News for Moderna and Amylyx Pharmaceuticals
Bad News for Moderna and Amylyx Pharmaceuticals
On this week's episode, Agustin addresses the unfortunate outcome of the FDA advisory board for Amylyx Pharmaceuticals (... Read more
11 Apr 2022
•
43mins
No Accelerated Approvals for You!
No Accelerated Approvals for You!
On this week's episode, Agustin shares his opinion on recent developments within the Covid landscape and the potential f... Read more
28 Mar 2022
•
41mins